Table IVA.
Cross-sectional results*
| Baseline |
1 Year |
2 Years |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PSV | APD | P | PSV | APD | P | PSV | APD | P | |||
| T1ρ cross-sectional | No lesion > Lesion | MF | 1.2% | 15.0% | 0.03 | 3.8% | 18.9% | 0.02 | <1% | – | – |
| MT | 3.8% | 19.8% | 0.03 | 4.6% | 27.9% | 0.03 | 4.3% | 24.8% | 0.02 | ||
| LF | 4.2% | 29.1% | 0.02 | 1.5% | 32.6% | 0.02 | 3.0% | 40.0% | 0.03 | ||
| LT | 1.0% | 25.5% | 0.02 | <1% | – | – | <1% | – | – | ||
| TrF | 6.9% | 16.4% | 0.03 | 1.3% | 25.2% | 0.04 | <1% | – | – | ||
| P | 0.2% | 16.3% | 0.03 | 0.0% | – | – | 0.0% | – | – | ||
| No lesion < Lesion | MF | <1% | – | – | <1% | – | – | 1.2% | 28.9% | 0.03 | |
| MT | 3.1% | 17.6% | 0.03 | <1% | – | – | 1.5% | 22.6% | 0.03 | ||
| LF | 3.7% | 17.9% | 0.03 | <1% | – | – | 1.2% | 20.8% | 0.04 | ||
| LT | 9.2% | 23.6% | 0.03 | 4.1% | 31.4% | 0.03 | 1.7% | 30.8% | 0.03 | ||
| TrF | <1% | – | – | <1% | – | – | <1% | – | – | ||
| P | 1.1% | 25.9% | 0.04 | <1% | – | – | 1.6% | 26.9% | 0.04 | ||
| T2 cross-sectional | No lesion > Lesion | MF | 6.9% | 17.5% | 0.03 | <1% | – | – | 1.4% | 32.1% | 0.03 |
| MT | 3.8% | 15.2% | 0.03 | <1% | – | – | 5.3% | 28.4% | 0.02 | ||
| LF | <1% | – | – | <1% | – | – | 6.1% | 40.8% | 0.02 | ||
| LT | 1.0% | 22.1% | 0.03 | <1% | – | – | 0% | – | – | ||
| TrF | <1% | – | – | <1% | – | – | 1.1% | 34.2% | 0.04 | ||
| P | <1% | – | – | <1% | – | – | <1% | – | – | ||
| No lesion < Lesion | MF | 0% | – | – | 1.0% | 21.9% | 0.03 | <1% | – | – | |
| MT | 0% | – | – | 17.6% | 30.5% | 0.02 | 11.5% | 29.1% | 0.03 | ||
| LF | 2.2% | 18.0% | 0.03 | 1.5% | 20.7% | 0.03 | <1% | – | – | ||
| LT | 2.8% | 25.8% | 0.02 | 8.6% | 27.7% | 0.02 | 4.3% | 33.0% | 0.03 | ||
| TrF | 1.9% | 15.8% | 0.03 | 1.6% | 17.6% | 0.03 | <1% | – | – | ||
| P | <1% | – | – | <1% | – | – | <1% | – | – | ||
P, patella.
*
Compartments with <1% of PSV do not have APD and P values displayed. Compartments with the largest PSV are bolded.